FDC Limited said that it has secured Good Manufacturing Practice (GMP) certificate for its ophthalmic facility in Aurangabad, Maharashtra from the UK Medicines and Healthcare Products Regulatory Agency (UK MHRA).

The Indian pharma company said that the GMP certificate continues with its approved status from the UK agency for the ophthalmic facility in Waluj. The certificate was issued based on the recent GMP inspection, which was remotely held by the UK MHRA between 6th and 9th September 2021.

  Aurangabad, FDC Limited, India, Maharashtra, UK Medicines and Healthcare Products Regulatory Agency, UK MHRA, Waluj